A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment
Clinical trial NCT00999336 · COMPLETED
Trial details
- NCT number
- NCT00999336
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-31
- Primary completion
- 2010-02-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.